Zühlke vs ML6: full comparison for 2026
Quick verdict
Zühlke (4.0/5) edges ahead of ML6 (4.0/5) overall. Zühlke is the better choice for swiss and European health and finance firms. ML6 is the stronger option for benelux firms wanting advice from builders. The right choice depends on how independent you need the advice to be, your regulatory exposure, and your budget.
Zühlke vs ML6: head-to-head summary
| Criterion | Zühlke | ML6 |
|---|---|---|
| Founded | 1968 | 2013 |
| HQ | Schlieren, Switzerland | Ghent, Belgium |
| Team size | ~1,600 | 140+ |
| Rating | 4.0 / 5 | 4.0 / 5 |
| Primary differentiator | Partner-owned advisory and engineering for regulated health and finance work | Use-case discovery from engineers who also handle EU AI Act requirements |
| Pricing model | Consulting and project fees; rates not published | Project fees; rates on request |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | EU AI Act, GDPR, Azure | EU AI Act, GDPR, Google Cloud |
| Industries served | Healthcare, Medical devices, Banking, Insurance, Manufacturing | Manufacturing, Media, Retail, Public sector, Financial services |
Zühlke vs ML6: overview
Zühlke
Zühlke was founded in Switzerland in 1968, is headquartered in Schlieren near Zurich, and is owned by its partners. Directory figures put it at about 1,600 people across Europe and Asia. Its data and AI consultants work on strategy, governance, and responsible AI, mostly for health and financial clients, and the same firm builds the resulting systems. Partner ownership means no private equity or parent company is pushing a sales agenda.
ML6
ML6 has been building AI in Ghent since 2013 and employs 140+ people in Belgium, Germany, and the Netherlands. Its strategy work covers ambition-setting workshops, use-case discovery, and EU AI Act questions, and OpenAI named it a services partner in June 2025. Most clients go on to build with ML6, so the advice is grounded in engineering reality but not neutral about who builds.
Services and capabilities: Zühlke vs ML6
| Capability | Zühlke | ML6 |
|---|---|---|
| Readiness assessment | ✓ | ✗ |
| Use-case prioritization | ✗ | ✓ |
| TCO / ROI modeling | ✗ | ✗ |
| AI governance & EU AI Act | ✓ | ✓ |
| Build vs. buy advice | ✗ | ✗ |
| Independent audit or assurance | ✗ | ✗ |
| Roadmap any vendor can implement | ✗ | ✗ |
| Delivery capability after advice | ✓ | ✓ |
Frameworks and platforms: Zühlke vs ML6
| Framework / platform | Zühlke | ML6 |
|---|---|---|
| EU AI Act | ✓ | ✓ |
| GDPR | ✓ | ✓ |
| DORA | N/A | N/A |
| NIST AI RMF | N/A | N/A |
| ISO/IEC 42001 | N/A | N/A |
| Azure | ✓ | N/A |
| AWS | ✓ | N/A |
| Google Cloud | N/A | ✓ |
Pricing comparison: Zühlke vs ML6
| Criterion | Zühlke | ML6 |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed-scope assessment, Multi-use-case advisory, Delivery team | Fixed-scope assessment, Delivery team |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Zühlke vs ML6
| Dimension | Zühlke | ML6 |
|---|---|---|
| Best company size | Mid-market to enterprise | Startup to mid-market |
| Best industries | Healthcare, Medical devices, Banking | Manufacturing, Media, Retail |
| Best use cases | Responsible AI planning for a medical-device maker., AI governance at a Swiss bank or insurer. | Use-case workshops for a Belgian or Dutch company., Checking feasibility before committing to a build. |
| Typical project type | Fixed-scope assessment | Fixed-scope assessment |
Zühlke vs ML6: pros and cons
| Zühlke | |
|---|---|
| + | Partner-owned, with no investor or parent shaping priorities |
| + | Long experience with medical-device and financial regulation |
| + | Advice and engineering in one firm |
| - | Swiss rates are high |
| - | Advice usually leads into its own delivery |
| - | Headcount figures come from directories |
| ML6 | |
|---|---|
| + | Feasibility advice comes from people who build |
| + | EU regulation is routine in its projects |
| + | Strong Belgian and German client base |
| - | Advice usually leads into its own engineering work |
| - | OpenAI partnership may color model recommendations |
| - | Limited footprint outside the Benelux and Germany |
Who should choose Zühlke?
A typical fit: responsible AI planning for a medical-device maker.
Partner-owned advisory and engineering for regulated health and finance work. Minimum engagement is not publicly disclosed. Works best with clients in Healthcare, Medical devices, Banking, Insurance, Manufacturing.
Who should choose ML6?
A typical fit: use-case workshops for a Belgian or Dutch company.
Use-case discovery from engineers who also handle EU AI Act requirements. Minimum engagement is not publicly disclosed. Works best with clients in Manufacturing, Media, Retail, Public sector, Financial services.
Decision matrix: Zühlke vs ML6
| Your situation | Recommended choice |
|---|---|
| You want advice with no build contract attached | Neither; write the build as a separate decision |
| Finance needs run costs before approving anything | Neither lists cost modeling; ask for a sample |
| Some of your use cases may be high-risk under the EU AI Act | Both cover AI Act classification |
| You need an outside check on a system already built | Neither; use a dedicated auditor |
| You want the same firm to build what it recommends | Both can deliver |
| Your budget is at the lower end | Compare: Zühlke (Not disclosed) vs ML6 (Not disclosed) |
| You need advisers in many countries at once | Zühlke |
Use case fit: Zühlke vs ML6
| Use case | Zühlke fit | ML6 fit | Winner |
|---|---|---|---|
| Responsible AI planning for a medical-device maker. | Strong | Limited | Zühlke |
| AI governance at a Swiss bank or insurer. | Strong | Limited | Zühlke |
| Use-case workshops for a Belgian or Dutch company. | Limited | Strong | ML6 |
| Checking feasibility before committing to a build. | Limited | Strong | ML6 |
Verdict: Zühlke vs ML6
Zühlke (4.0/5) is the stronger overall choice for most AI Advisory projects. Partner-owned advisory and engineering for regulated health and finance work.
ML6 (4.0/5) is worth a look if you need checking feasibility before committing to a build. If your situation matches that, ML6 is a competitive option.
Related comparisons
Zühlke vs ML6 FAQ
Is Zühlke better than ML6?
Zühlke (4.0/5) scores higher overall, but "better" depends on your use case. Zühlke's strongest advantage: partner-owned, with no investor or parent shaping priorities. ML6's strongest advantage: feasibility advice comes from people who build.
How do Zühlke and ML6 differ in pricing?
Zühlke's pricing: consulting and project fees; rates not published. ML6's pricing: project fees; rates on request. Any hourly bands shown come from Clutch, not a published rate card, so a scoping call is still needed for a project quote.
Which is better for enterprise: Zühlke or ML6?
Zühlke is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each firm before shortlisting.
What are the main differences between Zühlke and ML6?
Zühlke's primary differentiator is: partner-owned advisory and engineering for regulated health and finance work. ML6's primary differentiator is: use-case discovery from engineers who also handle EU AI Act requirements. They also differ in team size (~1,600 vs 140+), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Healthcare, Medical devices vs Manufacturing, Media).
Verify all details directly with each firm before making a decision.